Nyxoah SA

NASDAQ:NYXH   12:34:37 PM EDT
10.23
+0.47 (+4.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)261.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.1 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$10.90
50-Day MA$13.92
200-Day MA$20.06
See more pivots

Nyxoah SA Stock, NASDAQ:NYXH

Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435
Belgium
Phone: +32.10.22.23.55
Number of Employees: 105.8

Description

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.